✦ LIBER ✦

Cystic degeneration of thymic Hodgkin's disease following radiation therapy

✍ Scribed by Hugh C. Kim; John Nosher; Alexander Haas; William Sweeney; Ralph Lewis

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 770 KB
Volume: 55
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19850115)55:2<354::aid-cncr2820550209>3.0.co;2-p

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronic granulocytic leukemia following

Chronic granulocytic leukemia following radiation therapy for Hodgkin's disease

✍ Paul S. Ritch; Tom Anderson; Gerald A. Hanson; Anthony V. Pisciotta 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 605 KB

Radiation therapy of Hodgkin's disease:

Radiation therapy of Hodgkin's disease: Significance of splenic involvement

✍ William U. Shipley; Anthony J. Piro; Samuel Hellman 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 574 KB

Radiation therapy in the management of b

Radiation therapy in the management of bulky mediastinal Hodgkin's disease

✍ Robert A. Behar; Richard T. Hoppe 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 2 views

ZO patients with bulky mediastinal Hodgkin's Disease (maximum mediastinal width divided by the maximum intrathoracic diameter for a mediastinal mass ratio (MMR) > 0.33 were treated at Stanford University with definitive radiation therapy alone. The majority of these patients were selected to receive

Extended field radiation therapy in Hodg

Extended field radiation therapy in Hodgkin's disease. Analysis of failures

✍ William B. Mill; Lily A. Palmer-Hanes; James A. Purdy; Thomas W. Tillack; Edward 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 678 KB

The place of radiation therapy in the tr

The place of radiation therapy in the treatment of Hodgkin's disease

✍ Samuel Hellman; Peter Mauch; Robert L. Goodman; David S. Rosenthal; William C. M 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

The eight-drug/radiation therapy program

The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease. A follow-up report

✍ David J. Straus; Jane Myers; Sharon Passe; Charles W. Young; Lourdes Z. Nisce; B 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 829 KB

Eighty-four evaluable patients with advanced Hodgkin's disease (Stages IIB, IIIA age > 35 or mixed cellularity or lymphocyte depletion histology, IIIB, IVA, and IVB) were treated with alternating monthly MOPP and Adriamycin, bleomycin, dacarbazine, and vinblastine (ABDV). Radiation therapy (RT), 200